SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-042715
Filing Date
2020-09-08
Accepted
2020-09-08 07:35:50
Documents
7
Period of Report
2020-09-08

Document Format Files

Seq Description Document Type Size
1 6-K ck0001479615-6k_20200908.htm 6-K 31207
2 EX-99.1 ck0001479615-ex991_8.htm EX-99.1 24943
3 EX-99.2 ck0001479615-ex992_7.htm EX-99.2 18086
4 EX-99.3 ck0001479615-ex993_6.htm EX-99.3 71482
5 GRAPHIC gkxpudeek0nb000001.jpg GRAPHIC 4863
6 GRAPHIC ghilpvokwpbe000001.jpg GRAPHIC 4863
7 GRAPHIC gkeqqwjrcouj000001.jpg GRAPHIC 4863
  Complete submission text file 0001564590-20-042715.txt   167234
Mailing Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address 72 HAMMERSMITH ROAD LONDON X0 W14 8TH 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-39487 | Film No.: 201162962
SIC: 2834 Pharmaceutical Preparations